Verition Fund Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Verition Fund Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,469	Closed	-$282K	–	3637
2024 Q3	$282K	Buy	+8,469	New	+$292K	﹤0.01%	2683

Verition Fund Management's LBPH Position: Q4 2024 in Review

Verition Fund Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 8,469 shares — an estimated $282K sold.

Verition Fund Management first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $282K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Verition Fund Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Verition Fund Management sold 8,469 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $282K.
Verition Fund Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Verition Fund Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $282K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.